EP 4370144 A1 20240522 - GLUTAHTIONE C4 AGAINST AIRWAY AFFECTIONS
Title (en)
GLUTAHTIONE C4 AGAINST AIRWAY AFFECTIONS
Title (de)
GLUTAHUTION C4 GEGEN ATEMWEGSERKRANKUNGEN
Title (fr)
GLUTAHTIONE C4 CONTRE LES AFFECTIONS DES VOIES RESPIRATOIRES
Publication
Application
Priority
- IT 202100018605 A 20210714
- IB 2022056453 W 20220713
Abstract (en)
[origin: WO2023285984A1] The present invention relates to the compound glutathione C4 (GSH-C4) for use in the treatment of respiratory airways pathologies as well as to a composition comprising said compound, optionally combined with at least one additional active substance for said use.
IPC 8 full level
A61K 38/06 (2006.01); A61K 9/00 (2006.01); A61K 9/12 (2006.01); A61K 38/07 (2006.01); A61P 11/00 (2006.01)
CPC (source: EP)
A61K 9/0043 (2013.01); A61K 38/063 (2013.01); A61K 47/02 (2013.01); A61K 47/183 (2013.01); A61K 47/36 (2013.01); A61P 11/00 (2017.12)
Citation (search report)
See references of WO 2023285984A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2023285984 A1 20230119; CN 117693352 A 20240312; EP 4370144 A1 20240522
DOCDB simple family (application)
IB 2022056453 W 20220713; CN 202280049985 A 20220713; EP 22743925 A 20220713